3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 25 0 0 0 0 0 0 0999 V2000
1.2833 2.2711 -0.8151 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2833 2.2712 0.8151 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1115 -2.1527 0.7967 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.1116 -2.1527 -0.7966 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7127 0.0607 -0.0059 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7127 0.0608 0.0058 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0268 0.6599 -0.2427 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0268 0.6600 0.2427 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0204 -0.7709 0.2785 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0204 -0.7709 -0.2785 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5820 1.0149 -0.3602 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5819 1.0149 0.3602 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5551 -1.0832 0.4037 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5551 -1.0831 -0.4037 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5307 0.7196 -1.2132 H 0 0 0 0 0 0 0 0 0 0 0 0
3.5442 1.3271 0.4548 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.5306 0.7197 1.2133 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.5443 1.3272 -0.4546 H 0 0 0 0 0 0 0 0 0 0 0 0
3.5041 -0.8439 1.2567 H 0 0 0 0 0 0 0 0 0 0 0 0
3.4908 -1.4582 -0.4303 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.5040 -0.8438 -1.2567 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.4910 -1.4583 0.4302 H 0 0 0 0 0 0 0 0 0 0 0 0
2.1219 2.7322 -0.9893 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.1218 2.7321 0.9894 H 0 0 0 0 0 0 0 0 0 0 0 0
1 11 1 0 0 0 0
1 23 1 0 0 0 0
2 12 1 0 0 0 0
2 24 1 0 0 0 0
3 13 2 0 0 0 0
4 14 2 0 0 0 0
5 6 1 0 0 0 0
5 11 2 0 0 0 0
5 13 1 0 0 0 0
6 12 2 0 0 0 0
6 14 1 0 0 0 0
7 9 1 0 0 0 0
7 11 1 0 0 0 0
7 15 1 0 0 0 0
7 16 1 0 0 0 0
8 10 1 0 0 0 0
8 12 1 0 0 0 0
8 17 1 0 0 0 0
8 18 1 0 0 0 0
9 13 1 0 0 0 0
9 19 1 0 0 0 0
9 20 1 0 0 0 0
10 14 1 0 0 0 0
10 21 1 0 0 0 0
10 22 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
3-hydroxy-2-(2-hydroxy-5-oxocyclopenten-1-yl)cyclopent-2-en-1-one
4.2 InChl
InChI=1S/C10H10O4/c11-5-1-2-6(12)9(5)10-7(13)3-4-8(10)14/h11,13H,1-4H2
4.3 InChlKey
TYQPFQRKZPTHKH-UHFFFAOYSA-N
4.4 Canonical SMILES
C1CC(=O)C(=C1O)C2=C(CCC2=O)O
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病